Characterization of Regulated Intron Retention in T Cell Activation
Characterization of Regulated Intron Retention in T Cell Activation
批准号:
8882260
负责人:
Robert G. Hawley
金额:
$19.06万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2017-06-30
关键词:
3&apos Untranslated RegionsAlternative SplicingAttentionBiological ModelsCD4 Positive T LymphocytesCD8B1 geneChIP-seqCharacteristicsChromatinComputer AnalysisCoupledCouplingDimensionsDiseaseDrug TargetingEpigenetic ProcessEukaryotaFutureGene Expression ProfileGene Expression RegulationGenesGenetic TranscriptionHealthHistonesHumanHypersensitivityImmune System DiseasesImmune responseImmune systemImmunologic Deficiency SyndromesInformation SystemsIntronsMapsMessenger RNAMolecularMusPathway interactionsPlayPolyadenylationPost-Transcriptional RegulationPrevalenceProcessProxyPublic HealthRNA Polymerase IIRNA ProcessingRNA SplicingRegulationRoleSeptic ShockSiteSystemT-Cell ActivationT-LymphocyteTherapeuticTranscription Factor AP-1Transcriptional RegulationWorkabstractingadaptive immunitycell typecomputer frameworkepigenomeepigenomicsgenome-widehuman datainsightinterestmRNA Transcript Degradationnovelprogramsresponsetranscriptome sequencingtranscriptomics
中文摘要
描述(由申请人提供):项目摘要/摘要T细胞活化是免疫应答的重要步骤,异常导致致病性疾病,包括免疫缺陷、感染性休克和自身免疫性疾病。激活过程涉及转录和转录后水平的基因表达调控的协调程序。我们在人CD 4 + T细胞中的初步工作表明,受调节的内含子保留与mRNA降解偶联可能作为T细胞活化的一种新的转录后调节机制。内含子保留是真核生物可变剪接的主要形式之一。然而,其在基因调控中的功能参与尚未得到很好的探索。我们建议通过实现以下具体目标来弥合差距。目的1:描述内含子保留的定义特征。我们的初步结果表明内含子保留是基因和内含子特异性的。内含子保留基因与独特的表观遗传状态相关。序列和染色质的签名将有助于铺平道路,为未来的IR机制的研究。我们还建议检查跨细胞类型和物种的监管内含子保留的保护。为了了解其保守性的程度,我们建议收集转录组谱(RNA-Seq),RNA聚合酶II(ChIP-Seq)的全基因组占有率,以及人类CD 8 + T细胞和小鼠CD 4 + T细胞的其他表观基因组数据。将使用综合计算分析来评估内含子保留的普遍性及其在免疫系统激活中的功能作用。总的来说,来自这些系统的数据将为内含子保留的核心特征及其在序列、表观遗传和网络水平上的调控提供新的见解。目的2:了解内含子保留与其他基因调控方式的关系。为了全面了解激活过程的调节,重要的是要研究它们如何协同工作。我们将确定转录调控、受调控的内含子保留和3'非翻译区缩短之间的分工,这是T细胞活化过程中突出的另一种转录后调控模式。这项工作有望为内含子保留及其调控的分子机制提供线索,并为我们理解适应性免疫反应的调控开辟了新的维度。此外,我们预计在这个项目中开发的综合计算框架是有用的研究在其他系统中的内含子保留。
英文摘要
DESCRIPTION (provided by applicant): Project Summary/Abstract T cell activation is an essential step in immune response and abnormalities result in pathogenic conditions, including immunodeficiency, septic shock and auto-immune diseases. The activation process involves a coordinated program of gene expression regulations at both transcriptional and post-transcriptional levels. Our preliminary work in human CD4+ T cells demonstrated that regulated intron retention coupled with mRNA degradation may serve as a novel post- transcriptional regulatory mechanism underlying T cell activation. Intron retention is one of the key forms of alternative splicing in eukaryotes. However, its functional involvement in gene regulation has not been well explored. We propose to bridge the gap by accomplishing the following specific aims. Aim 1: Characterize the defining features of intron retention. Our preliminary results showed that intron retention is gene- and intron- specific. Intron-retained genes are associated with a unique epigenetic state. The sequence and chromatin signatures will help pave the path for future mechanistic studies of IR. We also propose to examine the conservation of regulated intron retention across cell-types and species. To understand the extent of its conservation, we propose to collect transcriptomic profile (RNA-Seq), genome-wide occupancy of RNA Polymerase II (ChIP-Seq), as well as other epigenomic data for human CD8+ T cells and mouse CD4+ T cells. An Integrated computational analysis will be used to assess the prevalence of intron retention and its functional role in immune system activation. Collectively, data from these systems will provide novel insights into the core features of intron retention and its regulation at the sequence, epigenetic and network level. Aim 2: Understand the connection of regulated intron retention with other modes of gene regulation. To gain a comprehensive understanding of the regulation of the activation process, it is important to examine how they work in concert. We will determine the division of labor between transcriptional regulation, regulated intron retention, and shortening of 3' untranslated region, another mode of post-transcriptional regulation prominent in the T cell activation process. The proposed work promises to yielding clues to the molecular mechanism of intron retention and its regulation, and opening up a new dimension in our understanding of the regulation of adaptive immune response. In addition, we anticipate the integrative computational frameworks developed in this project to be useful for studying intron retention in other systems.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1101/gad.268797.115
发表时间:
2016-01-15
期刊:
Genes & development
影响因子:
10.5
作者:
[Starnes LM, Su D, Pikkupeura LM, Weinert BT, Santos MA, Mund A, Soria R, Cho YW, Pozdnyakova I, Kubec Højfeldt M, Vala A, Yang W, López-Méndez B, Lee JE, Peng W, Yuan J, Ge K, Montoya G, Nussenzweig A, Choudhary C, Daniel JA]
通讯作者:
Daniel JA
DOI:
10.1093/nar/gkx234
发表时间:
2017-06-20
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Lai B, Lee JE, Jang Y, Wang L, Peng W, Ge K]
通讯作者:
Ge K
Global intron retention mediated gene regulation during CD4+ T cell activation.
CD4( ) T 细胞激活过程中全局内含子保留介导的基因调控
DOI:
10.1093/nar/gkw591
发表时间:
2016-08-19
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Ni T, Yang W, Han M, Zhang Y, Shen T, Nie H, Zhou Z, Dai Y, Yang Y, Liu P, Cui K, Zeng Z, Tian Y, Zhou B, Wei G, Zhao K, Peng W, Zhu J]
通讯作者:
Zhu J
DOI:
10.14218/erhm.2017.00022
发表时间:
2017-07
期刊:
Exploratory research and hypothesis in medicine
影响因子:
--
作者:
[Hawley RG]
通讯作者:
Hawley RG
Characterization of Regulated Intron Retention in T Cell Activation
-
批准号:8772992
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2014
-
负责人:Robert G. Hawley
-
依托单位:
Embryoid Body-derived Hematopoietic Stem Cell Lines
-
批准号:6644816
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Molecular Chimerism Therapy for Hemophilia A
-
批准号:7446784
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Embryoid Body-derived Hematopoietic Stem Cell Lines
-
批准号:6921361
-
项目类别:
-
资助金额:$40.28万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Lentiviral Vectors for Position-Independent Expression
-
批准号:6746914
-
项目类别:
-
资助金额:$43.58万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Lentiviral Vectors for Position-Independent Expression
-
批准号:6638689
-
项目类别:
-
资助金额:$34.7万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Lentiviral Vectors for Position-Independent Expression
-
批准号:6330739
-
项目类别:
-
资助金额:$34.7万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Molecular Chimerism Therapy for Hemophilia A
-
批准号:7657304
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Embryoid Body-derived Hematopoietic Stem Cell Lines
-
批准号:6527693
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Lentiviral Vectors for Position-Independent Expression
-
批准号:6537868
-
项目类别:
-
资助金额:$34.7万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Embryoid Body-derived Hematopoietic Stem Cell Lines
-
批准号:6370649
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Embryoid Body-derived Hematopoietic Stem Cell Lines
-
批准号:6768683
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2001
-
负责人:Robert G. Hawley
-
依托单位:
Molecular Chimerism Therapy for Hemophilia A
-
批准号:7140951
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:Robert G. Hawley
-
依托单位:
Molecular Chimerism Therapy for Hemophilia A
-
批准号:7251963
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2000
-
负责人:Robert G. Hawley
-
依托单位:
海外基金